Nan Fung Group Holdings’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-274,488
| Closed | -$376K | – | 47 |
|
|
2024
Q2 | $376K | Hold |
274,488
| – | – | 0.4% | 27 |
|
|
2024
Q1 | $1.03M | Hold |
274,488
| – | – | 0.95% | 24 |
|
|
2023
Q4 | $2.69M | Buy |
274,488
+137,833
| +101% | +$1.35M | 1.68% | 12 |
|
|
2023
Q3 | $1.14M | Hold |
136,655
| – | – | 0.92% | 18 |
|
|
2023
Q2 | $1.82M | Hold |
136,655
| – | – | 1.16% | 18 |
|
|
2023
Q1 | $1.58M | Hold |
136,655
| – | – | 1.08% | 18 |
|
|
2022
Q4 | $1.12M | Sell |
136,655
-8,185
| -6% | -$67K | 0.77% | 18 |
|
|
2022
Q3 | $841K | Hold |
144,840
| – | – | 0.54% | 22 |
|
|
2022
Q2 | $640K | Hold |
144,840
| – | – | 0.44% | 23 |
|
|
2022
Q1 | $1.32M | Sell |
144,840
-26,920
| -16% | -$245K | 0.63% | 20 |
|
|
2021
Q4 | $3.51M | Buy |
+171,760
| New | +$3.51M | 1.04% | 15 |
|